Literature DB >> 7534707

Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.

S N Wong1, V Shah, M J Dillon.   

Abstract

The prevalence and antigen specificity of anti-neutrophil cytoplasmic antibodies (ANCA) in sera from 23 children with active systemic lupus erythematosus (SLE) were studied utilizing indirect immunofluorescence and IgG and IgM ELISA using crude neutrophil extract and purified proteinase 3, myeloperoxidase, lactoferrin, cathepsin G and elastase. ANCA were present in 69% of SLE children and consisted of IgM and IgG antibodies of variable specificities, but did not correlate with organ involvement or disease activity. It remains unclear whether they have pathogenic significance or are epiphenomena in the category of polyclonal B-cell activation. However, their presence is entirely compatible with SLE even though they have hitherto been commonly associated with other systemic vasculitides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534707     DOI: 10.1007/bf01972971

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  4 in total

1.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

2.  ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE).

Authors:  R A Sinico; C Pozzi; A Radice; A Tincani
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 3.  The pathogenic role of antineutrophil cytoplasmic autoantibodies.

Authors:  B H Ewert; J C Jennette; R J Falk
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

4.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.

Authors:  M H Liang; S A Socher; M G Larson; P H Schur
Journal:  Arthritis Rheum       Date:  1989-09
  4 in total
  5 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.

Authors:  K Nishiya; H Chikazawa; S Nishimura; N Hisakawa; K Hashimoto
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 3.  Antineutrophil cytoplasm antibodies and vasculitis.

Authors:  M C Nash; M J Dillon
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

4.  Antineutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.

Authors:  A Bakkaloglu; R Topaloglu; U Saatçi; S Ozdemir; S Ozen; Y Başsoy; N Beşbaş
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 5.  DAMPening inflammation by modulating TLR signalling.

Authors:  A M Piccinini; K S Midwood
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.